Abstract:Abstract Background Since its emergence in late 2019, SARS-CoV-2 continues to pose a risk to healthcare personnel (HCP) and patients in healthcare settings. Although all clinical interactions likely carry some risk of transmission, human actions like coughing and care activities like aerosol-generating procedures likely have a higher risk of transmission. The rapid emergence and global spread of SARS-CoV-2 continues to create significant challenges in healthcare facilities, particularly with shortages of personal protective equipment (PPE) used by HCP. Evidence-based recommendations for what PPE to use in conventional, contingency, and crisis standards of care continue to be needed. Where evidence is lacking, the development of specific research questions can help direct funders and investigators. Objective Develop evidence-based rapid guidelines intended to support HCP in their decisions about infection prevention when caring for patients with suspected or known COVID-19. Methods IDSA formed a multidisciplinary guideline panel including frontline clinicians, infectious disease specialists, experts in infection control, and guideline methodologists with representation from the disciplines of public health, medical microbiology, pediatrics, critical care medicine and gastroenterology. The process followed a rapid recommendation checklist. The panel prioritized questions and outcomes. Then a systematic review of the peer-reviewed and grey literature was conducted. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess the certainty of evidence and make recommendations. Results The IDSA guideline panel agreed on eight recommendations, including two updated recommendations and one new recommendation added since the first version of the guideline. Narrative summaries of other interventions undergoing evaluations are also included. Conclusions Using a combination of direct and indirect evidence, the panel was able to provide recommendations for eight specific questions on the use of PPE for HCP providing care for patients with suspected or known COVID-19. Where evidence was lacking, attempts were made to provide potential avenues for investigation. There remain significant gaps in the understanding of the transmission dynamics of SARS-CoV-2 and PPE recommendations may need to be modified in response to new evidence. These recommendations should serve as a minimum for PPE use in healthcare facilities and do not preclude decisions based on local risk assessments or requirements of local health jurisdictions or other regulatory bodies.

Policy Update: Centers for Disease Control and Prevention Isolation Directives for Patients Exposed to Severe Acute Respiratory Syndrome Coronavirus 2

Application of the Centers for Disease Control and Prevention’s Isolation Directives for Patients Exposed to Severe Acute Respiratory Syndrome Coronavirus 2

Diagnosis, Treatment and Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children: Experts' Consensus Statement Updated for the Omicron Variant.

Coronavirus Disease 2019: In-Home Isolation Room Construction

Rewriting the playbook: infection prevention practices to mitigate nosocomial severe acute respiratory syndrome coronavirus 2 transmission

Assessing past versus present severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection: A survey of criteria for discontinuing precautions in asymptomatic patients testing positive on admission

Clinical Characteristics and Factors Associated with Long-Term Viral Excretion in Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study

Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2.

Recommendation about the perioperative prevention of infection to healthcare workers and the anesthesia management of children with SARS-CoV-2 infection.

How are countries responding differently to COVID-19: a systematic review of guidelines on isolation measures

Patient Follow‐up after Discharge after COVID‐19 Pneumonia: Considerations for Infectious Control

Respiratory care for the critical patients with 2019 novel coronavirus

Infectious Diseases Society of America Guidelines on Infection Prevention for Healthcare Personnel Caring for Patients with Suspected or Known COVID-19

Clinical Interventions for Severe and Critical COVID-19: What Are the Options

Airborne or Droplet Precautions for Health Workers Treating Coronavirus Disease 2019?

Validation of Centers for Disease Control and Prevention level 3 risk classification for healthcare workers exposed to severe acute respiratory coronavirus virus 2 (SARS-CoV-2)

Prevention of SARS-CoV-2 and respiratory viral infections in healthcare settings: current and emerging concepts

Airflow patterns in double occupancy patient rooms may contribute to roommate-to-roommate transmission of severe acute respiratory syndrome coronavirus 2

Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update

Home Use Guidance for Aerosol-Generating Procedures During the Coronavirus Disease 2019 Pandemic